Apurva Muklund Marfatia, MD

Offices

1 location · Sutter Bay Medical Foundation · 3,783 clinicians in this group

Looking this up.

Hospitals listed: El Camino Health. That is not proof they admit you there this week.

Plans that list them

3 plans · 3 carriers

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Marfatia’s office at (650) 254-5200 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

3 of 3 plans

Sort by

Plans whose provider directory lists this clinician

Alignment Health Sutter Advantage +More (HMO)	Alignment Health Plan	Listed	Oct 3, 2026
SCAN Strive (HMO C-SNP)	SCAN Health Plan	Listed	Oct 3, 2026
DualConnect (HMO D-SNP)	Santa Clara Family Health Plan	Listed	Sep 1, 2026

California Medical Board record

Licence A71771 · Current

Licensed to practise in California · since 2000 · expires 2027-12-31 · University of Bombay, Topiwala National Medical College.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend it
Overall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025

See every measure and the patient survey for El Camino Health

Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Sort by

Every scored measure at El Camino Health

Central Line Associated Bloodstream Infection (ICU + select Wards)Infections	0.291	Better	Oct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections	0.393	Better	Oct 2024 – Sep 2025
MRSA BacteremiaInfections	0	Better	Oct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths	0.96 (0.12 to 1.79) · 2,340 cases	No different	Jul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths	1.02 (0.76 to 1.28)	No different	Jul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths	167.38 (125.03 to 209.73) · 96 cases	No different	Jul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths	2.6 · 68 cases	None	Jul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths	7.1 · 185 cases	None	Jul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths	11.8 · 200 cases	None	Jul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths	8.9 · 814 cases	None	Jul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths	13 · 842 cases	None	Jul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths	9.6 · 361 cases	None	Jul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths	2.6 · 4,633 cases	None	Jul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths	0.16 (0 to 0.34) · 11,474 cases	No different	Jul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths	0.27 (0.1 to 0.45) · 11,626 cases	No different	Jul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths	3.14 (1.39 to 4.9) · 2,814 cases	No different	Jul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths	2 (0.61 to 3.39) · 1,327 cases	No different	Jul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths	2.11 (0.8 to 3.43) · 2,641 cases	No different	Jul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths	9.39 (4.18 to 14.6) · 1,287 cases	No different	Jul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths	6.57 (3.47 to 9.68) · 1,308 cases	No different	Jul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths	2.14 (0.71 to 3.57) · 827 cases	No different	Jul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths	0.6 (0.05 to 1.15) · 9,460 cases	No different	Jul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths	4.5 · 122 cases	None	Apr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections	0.993	No different	Oct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections	0.706	No different	Oct 2024 – Sep 2025
SSI - Colon SurgeryInfections	1.376	No different	Oct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits	15.5 · 218 cases	None	Jul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits	19.5 · 962 cases	None	Jul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits	3.8 · 200 cases	None	Jul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits	-17 · 922 cases	None	Jul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits	18.6 · 860 cases	None	Jul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits	18.7 · 827 cases	None	Jul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits	6.1 (4.5 to 8.2) · 313 cases	No different	Jan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits	13.4 (10.6 to 16.5) · 313 cases	No different	Jan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits	6.1 · 144 cases	None	Jul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits	10.3 · 80 cases	None	Jul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits	20.7 · 237 cases	None	Jul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits	12.8 (10 to 16.1) · 1,639 cases	No different	Jan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits	0.9 (0.8 to 1.1) · 1,619 cases	No different	Jan 2024 – Dec 2024

What patients said (1,535 patients answered, 22% of those asked)

Sort by

Patient survey stars by topic at El Camino Health

Cleanliness	4
Nurse communication	4
Doctor communication	4
Communication about medicines	3
Discharge information	3
Overall hospital rating	4
Quietness	2
Recommend hospital	5

Sort by

Share of patients giving the best answer at El Camino Health

Room was "always" clean	75%
Nurses "always" communicated well	79%
Doctors "always" communicated well	81%
Staff "always" explained	61%
Yes, staff "did" give patients this information	86%
Yes, staff "did" give patients information about help after discharge	86%
Doctors "always" explained things so they could understand	76%
Doctors "always" listened carefully	80%
Doctors "always" treated them with courtesy and respect	87%
Patients who gave a rating of "9" or "10" (high)	76%
Staff "always" explained new medications	76%
Nurses "always" explained things so they could understand	75%
Nurses "always" listened carefully	76%
Nurses "always" treated them with courtesy and respect	87%
"Always" quiet at night	47%
"YES", patients would definitely recommend the hospital	80%
Staff "always" explained possible side effects	46%
Yes, staff "did" give patients information about possible symptoms	86%

Original Medicare doctor bills

$81,030

Medicare paid this office $81,030 for 269 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Sort by

Largest Original Medicare bills

Return visit (30+ min)	157	$35,816	$116
New patient visit (60+ min)	106	$20,624	$195
Long return visit (40+ min)	35	$5,139	$143
Short return visit (20+ min)	38	$3,159	$75
Test to examine how well the lungs exchange gases	54	$3,128	$56

See all 8 services

Sort by

Every Original Medicare service billed

Return visit (30+ min)	157	$35,816	$116
New patient visit (60+ min)	106	$20,624	$195
Long return visit (40+ min)	35	$5,139	$143
Short return visit (20+ min)	38	$3,159	$75
Test to examine how well the lungs exchange gases	54	$3,128	$56
Test to determine lung volumes using sensors	48	$2,703	$54
Test to measure expiratory airflow and volume changes before and after medication administration	60	$2,311	$37
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	62	$1,517	$15

Who their Medicare patients are

269 Original Medicare patients in 2024. Average age 77 · Women 62% · Also on Medicaid 14% · Health risk score 1.41. At or below the middle of the specialty; the typical pulmonary disease clinician is at 2.13.

Conditions among them: High blood pressure 70% · COPD 44% · Coronary heart disease 31% · Chronic kidney disease 29% · Diabetes 28% · Heart failure 24% · Atrial fibrillation 21% · Cancer 19% · Depression 18% · Stroke 9% · Dementia 6%.

The office billed $308,302, Medicare allowed $109,649 and paid $81,030; for 838 services of 20 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Sort by

Original Medicare by year

2024	269	838	77	1.41	$308,302	$81,030
2023	260	722	77	1.28	$295,852	$83,168
2022	291	898	78	1.26	$334,842	$94,935
2021	267	838	78	1.35	$327,880	$97,184
2020	247	775	77	1.75	$272,926	$76,962
2019	385	1,464	76	1.74	$547,287	$143,878
2018	428	1,470	77	1.62	$529,471	$134,273
2017	416	1,395	76	1.72	$548,753	$146,110
2016	433	1,538	76	1.78	$521,814	$138,896
2015	428	1,381	77	1.69	$513,942	$146,901
2014	423	1,253	76	1.94	$519,708	$136,078
2013	473	1,471	76	1.95	$637,986	$159,480

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 8 services

Sort by

Original Medicare services billed in 2023

Return visit (30+ min)	162	$35,437	$116
New patient visit (60+ min)	110	$21,928	$199
Long return visit (40+ min)	32	$6,321	$162
Test to examine how well the lungs exchange gases	53	$3,506	$63
Test to determine lung volumes using sensors	47	$2,953	$59
Test to measure expiratory airflow and volume changes before and after medication administration	51	$2,166	$41
Short return visit (20+ min)	23	$1,958	$78
Test to measure expiratory airflow and volume	13	$401	$29

2022: 8 services

Sort by

Original Medicare services billed in 2022

Return visit (30+ min)	180	$38,353	$117
New patient visit (60+ min)	114	$22,748	$200
Long return visit (40+ min)	55	$8,448	$151
Test to examine how well the lungs exchange gases	90	$5,822	$63
Test to determine lung volumes using sensors	88	$5,232	$57
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes	12	$4,236	$94
Test to measure expiratory airflow and volume changes before and after medication administration	79	$3,255	$41
Test to measure expiratory airflow and volume	20	$595	$27

2021: 11 services

Sort by

Original Medicare services billed in 2021

Return visit (30+ min)	157	$35,698	$118
New patient visit (60+ min)	105	$21,528	$205
Long return visit (40+ min)	51	$10,762	$168
Critical care, first 30-74 minutes	12	$6,617	$201
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes	18	$4,490	$94
Test to examine how well the lungs exchange gases	68	$4,218	$62
Test to determine lung volumes using sensors	67	$3,796	$57
Test to measure expiratory airflow and volume changes before and after medication administration	59	$2,848	$48
Initial hospital care with moderate level of medical decision making at least 75 minutes	12	$2,268	$189
Short return visit (20+ min)	20	$1,714	$78
Test to measure expiratory airflow and volume	15	$417	$28

2020: 12 services

Sort by

Original Medicare services billed in 2020

Return visit (30+ min)	129	$24,457	$97
New patient visit (60+ min)	83	$16,469	$198
Critical care, first 30-74 minutes	29	$7,380	$211
Long return visit (40+ min)	36	$5,879	$137
Test to examine how well the lungs exchange gases	53	$3,205	$59
Test to measure expiratory airflow and volume changes before and after medication administration	47	$2,988	$62
Test to determine lung volumes using sensors	48	$2,686	$56
Critical care, each additional 30 minutes	15	$1,587	$106
Telephone medical discussion with physician, 11-20 minutes	19	$1,563	$74
Short return visit (20+ min)	12	$965	$74
Test to measure expiratory airflow and volume	14	$504	$36
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	16	$2	None

2019: 12 services

Sort by

Original Medicare services billed in 2019

Critical care, first 30-74 minutes	115	$49,862	$198
Return visit (30+ min)	159	$33,817	$100
New patient visit (60+ min)	91	$17,292	$190
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes	50	$9,045	$92
Long return visit (40+ min)	39	$7,047	$133
Test to examine how well the lungs exchange gases	84	$5,144	$58
Critical care, each additional 30 minutes	35	$4,983	$100
Test to measure expiratory airflow and volume changes before and after medication administration	75	$4,707	$61
Test to determine lung volumes using sensors	79	$4,598	$56
Short return visit (20+ min)	21	$1,583	$66
Test to measure expiratory airflow and volume	15	$631	$37
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	78	$8	None

2018: 13 services

Sort by

Original Medicare services billed in 2018

Critical care, first 30-74 minutes	97	$39,362	$195
Return visit (30+ min)	155	$29,453	$94
New patient visit (60+ min)	115	$20,799	$181
Long return visit (40+ min)	50	$8,776	$133
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes	51	$7,354	$91
Critical care, each additional 30 minutes	41	$5,886	$98
Test to examine how well the lungs exchange gases	106	$4,936	$46
Test to determine lung volumes using sensors	97	$4,915	$51
Test to measure expiratory airflow and volume changes before and after medication administration	104	$4,736	$45
New patient visit (45+ min)	14	$2,100	$150
Test to measure expiratory airflow and volume	20	$743	$35
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	78	$7	None
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram	12	$2	None

2017: 13 services

Sort by

Original Medicare services billed in 2017

Critical care, first 30-74 minutes	117	$49,804	$195
Return visit (30+ min)	147	$25,899	$94
New patient visit (60+ min)	117	$20,917	$179
Long return visit (40+ min)	68	$11,565	$133
Critical care, each additional 30 minutes	57	$9,838	$98
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes	46	$7,291	$92
Test to measure expiratory airflow and volume changes before and after medication administration	67	$3,966	$57
Test to examine how well the lungs exchange gases	70	$3,933	$54
Test to determine lung volumes using sensors	67	$3,608	$52
Initial hospital care with moderate level of medical decision making at least 75 minutes	13	$2,357	$181
New patient visit (45+ min)	12	$1,824	$152
Test to measure expiratory airflow and volume	12	$406	$34
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	52	$6	None

2016: 13 services

Sort by

Original Medicare services billed in 2016

Critical care, first 30-74 minutes	93	$35,375	$191
Return visit (30+ min)	144	$28,406	$93
New patient visit (60+ min)	105	$19,206	$183
Critical care, each additional 30 minutes	54	$11,092	$98
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes	64	$10,901	$91
Long return visit (40+ min)	48	$6,653	$128
Test to measure expiratory airflow and volume changes before and after medication administration	91	$5,186	$57
Test to examine how well the lungs exchange gases	95	$5,159	$54
Initial hospital care with moderate level of medical decision making at least 75 minutes	24	$4,196	$175
Test to determine lung volumes using sensors	72	$3,872	$54
Short return visit (20+ min)	14	$936	$58
Test to determine lung volumes using gas dilution or washout	16	$604	$36
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	78	$9	None

2015: 13 services

Sort by

Original Medicare services billed in 2015

Critical care, first 30-74 minutes	95	$34,518	$203
Return visit (30+ min)	164	$32,529	$98
New patient visit (60+ min)	119	$22,937	$193
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes	88	$15,329	$96
Critical care, each additional 30 minutes	44	$7,736	$103
Initial hospital care with moderate level of medical decision making at least 75 minutes	29	$5,559	$185
Test to measure expiratory airflow and volume changes before and after medication administration	75	$4,867	$64
Test to examine how well the lungs exchange gases	70	$4,086	$58
Test to determine lung volumes using sensors	68	$3,810	$56
Long return visit (40+ min)	20	$2,969	$129
Short return visit (20+ min)	37	$2,515	$63
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes	23	$2,302	$68
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	21	$2	None

2014: 13 services

Sort by

Original Medicare services billed in 2014

Critical care, first 30-74 minutes	105	$36,114	$195
Return visit (30+ min)	124	$23,245	$93
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes	119	$16,331	$91
New patient visit (60+ min)	82	$15,056	$184
Critical care, each additional 30 minutes	47	$10,148	$98
Initial hospital care with moderate level of medical decision making at least 75 minutes	38	$6,784	$174
Test to measure expiratory airflow and volume changes before and after medication administration	74	$4,729	$60
Test to examine how well the lungs exchange gases	67	$3,882	$54
Test to determine lung volumes using sensors	61	$3,426	$54
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes	22	$3,138	$64
Short return visit (20+ min)	36	$2,740	$64
New patient visit (45+ min)	14	$1,976	$141
Long return visit (40+ min)	14	$1,849	$132

2013: 14 services

Sort by

Original Medicare services billed in 2013

Critical care, first 30-74 minutes	97	$42,789	$191
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes	145	$22,266	$89
Return visit (30+ min)	133	$21,480	$91
New patient visit (60+ min)	92	$16,915	$184
Critical care, each additional 30 minutes	58	$11,506	$96
Initial hospital care with moderate level of medical decision making at least 75 minutes	47	$8,145	$170
Long return visit (40+ min)	36	$5,973	$133
Test to measure expiratory airflow and volume changes before and after medication administration	70	$4,679	$63
Test to examine how well the lungs exchange gases	62	$4,240	$64
Test to determine lung volumes using sensors	61	$3,962	$61
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes	29	$3,373	$62
Short return visit (20+ min)	40	$2,824	$58
Aspiration of initial secretion of lung airway using an endoscope	12	$1,727	$144
Irrigation and suction of lung airways to obtain cells using an endoscope	13	$883	$63

Medicaid work

$3,915 in 2019

Medicaid paid $3,915 for 27 billed services this clinician did in 2019, up to 12 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Sort by

Largest Medicaid services in 2019

Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes	27	$3,915

Sort by

Medicaid work by year

2019	27	1	12	$3,915

Drugs they prescribed that Part D paid

$622,024

Pharmacies billed $622,024 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 612) in 2024. At or below the middle of the specialty; the typical pulmonary disease clinician is at 0%.

193 generic and 419 brand-name prescriptions · $622,024 in drug cost · 13 antibiotic prescriptions to 12 people.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Sort by

Largest Part D drug costs

Ofev	29	$377,920	$13,032
Trelegy Ellipta	56	$49,444	$883
Breo Ellipta	93	$47,044	$506
Anoro Ellipta	46	$29,964	$651
Incruse Ellipta	51	$18,600	$365

See all 15 drugs

Sort by

Every Part D drug this clinician prescribed

Ofev	29	$377,920	$13,032
Trelegy Ellipta	56	$49,444	$883
Breo Ellipta	93	$47,044	$506
Anoro Ellipta	46	$29,964	$651
Incruse Ellipta	51	$18,600	$365
Spiriva Handihaler	20	$16,499	$825
Arnuity Ellipta	28	$8,302	$297
Dulera	17	$5,220	$307
Pulmicort Flexhaler	11	$2,861	$260
Wixela Inhub	23	$2,580	$112
Ventolin Hfa	18	$939	$52
Albuterol Sulfate Hfa	14	$498	$36
Prednisone	43	$320	$7
Fluticasone Propionate	13	$144	$11
Alendronate	12	$101	$8

Year by year

Sort by

Part D prescribing by year

2024	612	114	0% (0)	68%	$622,024
2023	577	111	0% (0)	64%	$687,566
2022	482	106	0% (0)	51%	$247,720
2021	518	95	0% (0)	64%	$274,645
2020	567	103	0% (0)	74%	$245,243
2019	689	120	0% (0)	67%	$271,924
2018	776	136	0% (0)	77%	$417,053
2017	836	124	0% (0)	72%	$372,781
2016	663	113	0% (0)	74%	$241,381
2015	521	100	0% (0)	68%	$272,299
2014	461	97	0% (0)	75%	$125,094
2013	558	99	0% (0)	74%	$125,962

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 18 drugs

Sort by

Part D drugs prescribed in 2023

Ofev	38	$485,917	$12,787
Breo Ellipta	66	$39,119	$593
Trelegy Ellipta	38	$32,352	$851
Anoro Ellipta	22	$18,661	$848
Incruse Ellipta	47	$18,486	$393
Spiriva Handihaler	21	$16,470	$784
Advair Diskus	16	$9,435	$590
Symbicort	20	$8,866	$443
Wixela Inhub	20	$4,150	$207
Flovent Hfa	16	$4,121	$258
Pulmicort Flexhaler	11	$2,680	$244
Arnuity Ellipta	11	$2,544	$231
Mycophenolate Mofetil	21	$2,288	$109
Albuterol Sulfate Hfa	22	$757	$34
Prednisone	47	$281	$6
Montelukast	13	$280	$22
Ondansetron	13	$177	$14
Alendronate	16	$141	$9

2022: 13 drugs

Sort by

Part D drugs prescribed in 2022

Breo Ellipta	55	$34,106	$620
Spiriva Handihaler	36	$19,359	$538
Incruse Ellipta	34	$18,573	$546
Eliquis	11	$14,837	$1,349
Anoro Ellipta	14	$11,407	$815
Symbicort	19	$8,534	$449
Wixela Inhub	29	$4,827	$166
Flovent Hfa	15	$4,028	$269
Mycophenolate Mofetil	41	$3,066	$75
Albuterol Sulfate Hfa	17	$1,092	$64
Azelastine	13	$544	$42
Prednisone	56	$410	$7
Alendronate	24	$280	$12

2021: 13 drugs

Sort by

Part D drugs prescribed in 2021

Spiriva	66	$47,210	$715
Incruse Ellipta	65	$32,551	$501
Breo Ellipta	53	$29,774	$562
Trelegy Ellipta	15	$14,588	$973
Anoro Ellipta	18	$12,894	$716
Spiriva Respimat	19	$10,092	$531
Wixela Inhub	36	$8,430	$234
Advair Diskus	14	$8,186	$585
Albuterol Sulfate Hfa	32	$1,388	$43
Mycophenolate Mofetil	21	$1,351	$64
Prednisone	55	$462	$8
Montelukast	11	$252	$23
Alendronate	19	$225	$12

2020: 16 drugs

Sort by

Part D drugs prescribed in 2020

Breo Ellipta	86	$53,724	$625
Spiriva	68	$45,441	$668
Incruse Ellipta	57	$24,862	$436
Trelegy Ellipta	21	$20,826	$992
Anoro Ellipta	34	$17,786	$523
Spiriva Respimat	33	$16,835	$510
Symbicort	14	$12,310	$879
Advair Diskus	15	$9,498	$633
Wixela Inhub	33	$7,632	$231
Pulmicort Flexhaler	12	$2,225	$185
Albuterol Sulfate Hfa	15	$1,210	$81
Proair Hfa	12	$974	$81
Ventolin Hfa	13	$848	$65
Prednisone	55	$464	$8
Fluticasone Propionate	11	$359	$33
Montelukast	20	$220	$11

2019: 18 drugs

Sort by

Part D drugs prescribed in 2019

Breo Ellipta	93	$51,439	$553
Spiriva	79	$51,418	$651
Spiriva Respimat	47	$22,629	$481
Advair Diskus	37	$22,339	$604
Anoro Ellipta	22	$17,613	$801
Incruse Ellipta	38	$17,271	$455
Trelegy Ellipta	17	$14,781	$869
Wixela Inhub	28	$7,863	$281
Combivent Respimat	11	$7,786	$708
Atrovent Hfa	15	$6,089	$406
Flovent Hfa	12	$4,318	$360
Proair Hfa	27	$2,702	$100
Pulmicort Flexhaler	12	$2,167	$181
Ventolin Hfa	15	$1,207	$80
Prednisone	91	$835	$9
Montelukast	19	$368	$19
Fluticasone Propionate	21	$326	$16
Alendronate	29	$262	$9

2018: 17 drugs

Sort by

Part D drugs prescribed in 2018

Spiriva	116	$62,487	$539
Advair Diskus	94	$57,511	$612
Breo Ellipta	91	$44,515	$489
Anoro Ellipta	40	$30,823	$771
Spiriva Respimat	47	$27,145	$578
Incruse Ellipta	50	$24,001	$480
Combivent Respimat	23	$15,235	$662
Symbicort	15	$9,546	$636
Atrovent Hfa	11	$4,187	$381
Proair Hfa	42	$3,690	$88
Ventolin Hfa	22	$2,402	$109
Pulmicort Flexhaler	12	$2,110	$176
Azathioprine	12	$588	$49
Prednisone	66	$544	$8
Fluticasone Propionate	42	$480	$11
Montelukast	13	$301	$23
Azithromycin	13	$90	$7

2017: 21 drugs

Sort by

Part D drugs prescribed in 2017

Spiriva	166	$76,763	$462
Advair Diskus	106	$63,988	$604
Incruse Ellipta	61	$25,092	$411
Breo Ellipta	45	$18,579	$413
Spiriva Respimat	45	$17,254	$383
Combivent Respimat	20	$13,678	$684
Anoro Ellipta	19	$10,658	$561
Eliquis	16	$9,800	$613
Symbicort	24	$8,510	$355
Advair Hfa	12	$5,598	$466
Atrovent Hfa	14	$4,644	$332
Pulmicort Flexhaler	13	$2,825	$217
Ventolin Hfa	19	$1,429	$75
Proair Hfa	19	$1,384	$73
Mycophenolate Mofetil	11	$993	$90
Azathioprine	18	$796	$44
Prednisone	73	$483	$7
Fluticasone Propionate	37	$445	$12
Montelukast	15	$367	$24
Alendronate	11	$135	$12
Azithromycin	15	$88	$6

2016: 18 drugs

Sort by

Part D drugs prescribed in 2016

Spiriva	114	$64,993	$570
Advair Diskus	103	$50,329	$489
Spiriva Respimat	73	$26,339	$361
Combivent Respimat	42	$17,678	$421
Symbicort	27	$7,789	$288
Flovent Hfa	16	$5,711	$357
Advair Hfa	11	$4,868	$443
Incruse Ellipta	17	$4,433	$261
Atrovent Hfa	14	$4,252	$304
Anoro Ellipta	11	$3,528	$321
Asmanex	13	$2,304	$177
Proair Hfa	18	$1,639	$91
Ventolin Hfa	11	$1,068	$97
Montelukast	11	$718	$65
Mycophenolate Mofetil	12	$653	$54
Prednisone	71	$372	$5
Fluticasone Propionate	20	$315	$16
Azithromycin	11	$77	$7

2015: 13 drugs

Sort by

Part D drugs prescribed in 2015

Esbriet	16	$129,243	$8,078
Spiriva	90	$52,045	$578
Advair Diskus	73	$38,344	$525
Spiriva Respimat	53	$16,203	$306
Combivent Respimat	35	$15,002	$429
Foradil	12	$3,723	$310
Flovent Hfa	12	$3,556	$296
Symbicort	11	$3,023	$275
Proair Hfa	15	$1,527	$102
Azathioprine	15	$918	$61
Fluticasone Propionate	34	$473	$14
Montelukast	15	$411	$27
Prednisone	56	$324	$6

2014: 6 drugs

Sort by

Part D drugs prescribed in 2014

Spiriva	139	$58,636	$422
Advair Diskus	92	$34,147	$371
Combivent Respimat	34	$13,635	$401
Proair Hfa	20	$1,340	$67
Fluticasone Propionate	32	$529	$17
Prednisone	49	$333	$7

2013: 10 drugs

Sort by

Part D drugs prescribed in 2013

Spiriva	213	$70,102	$329
Advair Diskus	83	$26,848	$323
Combivent Respimat	18	$6,175	$343
Flovent Hfa	12	$3,177	$265
Azelastine	17	$1,729	$102
Proair Hfa	19	$1,329	$70
Fluticasone Propionate	40	$852	$21
Methotrexate	11	$406	$37
Azithromycin	12	$132	$11
Prednisone	45	$125	$3

Money from drug and device companies

$469 in 2025

Sort by

Industry payments by year

2025	6	15	None	$469
2024	4	4	None	$210
2023	1	2	None	$38
2019	1	1	None	$125

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Sort by

Payments by company

GlaxoSmithKline	Nucala	$179	7 payments Meals for Nucala · 2025-11-06 · $32 Meals for Nucala · 2025-09-21 · $21 Meals for Nucala · 2025-08-18 · $34 Meals for Nucala · 2025-07-11 · $26 Meals for Nucala · 2025-06-19 · $26 Meals for Nucala · 2025-03-07 · $23 Meals for Nucala · 2025-01-17 · $17
Sanofi-Aventis U.S.	Dupixent	$99	1 payment Education for Dupixent · 2025-07-23 · $99
AstraZeneca Pharmaceuticals LP	Breztri	$64	2 payments Meals for Breztri · 2025-10-29 · $33 Meals for Breztri · 2025-09-02 · $31
Boehringer Ingelheim Pharmaceuticals	Ofev	$58	2 payments Meals for Jascayd · 2025-12-08 · $28 Meals for Ofev · 2025-05-15 · $30
Baxter Healthcare	Hillrom - Volara System	$56	2 payments Meals for Hillrom - Volara System · 2025-09-09 · $37 Meals for Hillrom - Volara System · 2025-08-26 · $19
Verona Pharma	Ohtuvayre	$14	1 payment Meals for Ohtuvayre · 2025-12-09 · $14

See all 15 published payments

Sort by

Every published payment

Verona Pharma	Meals · 2025-12-09	Ohtuvayre	$14
Boehringer Ingelheim Pharmaceuticals	Meals · 2025-12-08	Jascayd	$28
GlaxoSmithKline	Meals · 2025-11-06	Nucala	$32
AstraZeneca Pharmaceuticals LP	Meals · 2025-10-29	Breztri	$33
GlaxoSmithKline	Meals · 2025-09-21	Nucala	$21
Baxter Healthcare	Meals · 2025-09-09	Hillrom - Volara System	$37
AstraZeneca Pharmaceuticals LP	Meals · 2025-09-02	Breztri	$31
Baxter Healthcare	Meals · 2025-08-26	Hillrom - Volara System	$19
GlaxoSmithKline	Meals · 2025-08-18	Nucala	$34
Sanofi-Aventis U.S.	Education · 2025-07-23	Dupixent	$99
GlaxoSmithKline	Meals · 2025-07-11	Nucala	$26
GlaxoSmithKline	Meals · 2025-06-19	Nucala	$26
Boehringer Ingelheim Pharmaceuticals	Meals · 2025-05-15	Ofev	$30
GlaxoSmithKline	Meals · 2025-03-07	Nucala	$23
GlaxoSmithKline	Meals · 2025-01-17	Nucala	$17

See earlier years (2024, 2023, 2019)

2024: $210

Sort by

Payments by company in 2024

Sanofi-Aventis U.S.	Dupixent	$99	1 payment Education for Dupixent · 2024-09-04 · $99
Boehringer Ingelheim Pharmaceuticals	Ofev	$40	1 payment Meals for Ofev · 2024-11-07 · $40
Philips North America	(8874) Incourage	$38	1 payment Meals for (8874) Incourage · 2024-10-09 · $38
Amgen	Tezspire	$33	1 payment Meals for Tezspire · 2024-12-12 · $33

2023: $38

Sort by

Payments by company in 2023

Boehringer Ingelheim Pharmaceuticals	Ofev	$38	2 payments Meals for Ofev · 2023-09-13 · $20 Meals for Ofev · 2023-05-11 · $19

2019: $125

Sort by

Payments by company in 2019

GlaxoSmithKline	Anoro	$125	1 payment Meals for Anoro · 2019-03-07 · $125

Professional record

NPI: 1033290812
Licence: CA A71771California A71771: Current · expires 2027-12-31
Group: Sutter Bay Medical Foundation
Gender: Male

More record details

Sole proprietor: No
Taxonomy: Federal specialty code 207RP1001X (207RP1001X)
Mailing address: 2350 W El Camino Real, 2nd Floor, Mountain View, CA, 94040
NPI first listed: 2006-10-18
NPI last updated: 2011-12-09

This is when the NPI record was last certified, not a medical board exam.